A: The variant NC_000022.11:g.42129084del in gene CYP2D6 is classified as 'Benign/Likely_benign|drug_response|other' for Tamoxifen_response|Deutetrabenazine_response|not_provided|Debrisoquine,_poor_metabolism_of. Molecular consequence: SO:0001589: frameshift_variant,SO:0001627: intron_variant. Variant type: Deletion. Disease database links: MedGen:CN078013|MedGen:CN258189|MedGen:C3661900|MedGen:C1837156. Review status: criteria provided, multiple submitters, no conflicts.